PMPRB report shows higher-cost medicines driving a 14.1% growth in private plan drug costs in 2023
Imported from official source
Report explores the drivers of growth in prescription drug costs for private drug plans
This version
- Version
- 1 of 1
- Recorded
- October 03, 2026 20:43
- Change
- Initial
- Content hash
a023ffdfbf8d57ea75d20cf6f1c3bc74- All versions
- Revision history